The VINCEnT ( VINflunine Cisplatin inEligible Trial ) brand, founded in 2007 (United States), from 496 sister brands and 17478 competing brands. VINCEnT ( VINflunine Cisplatin inEligible Trial ) is owned by BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York VINCEnT ( VINflunine Cisplatin inEligible Trial ) belongs to the Drug Manufacturers business sector.

VINCEnT ( VINflunine Cisplatin inEligible Trial ) is a brand of BRISTOL-MYERS SQUIBB COMPANY (BMY) Sustainability

International deposit : 2007 Business sector Drug Manufacturers
Here is the evolution of interest in BRISTOL-MYERS SQUIBB COMPANY "sustainability" criteria around the world over the past five years. The graph shows the evolution of the search rate over time, where the value 100 indicates the week with the most searches.
What is the brand's web response on its sustainability
Result of Google's query: "VINCEnT ( VINflunine Cisplatin inEligible Trial ) sustainability"
Sustainability -> Share price